Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
Crocs Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Crocs wird ein jährliches Gewinn- und Umsatzwachstum von 5.6% bzw. 5.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 6.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 30.8% betragen.
Wichtige Informationen
5.6%
Wachstumsrate der Gewinne
6.1%
EPS-Wachstumsrate
Luxury Gewinnwachstum | 14.6% |
Wachstumsrate der Einnahmen | 5.6% |
Zukünftige Eigenkapitalrendite | 30.8% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 13 May 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Crocs, Inc. (NASDAQ:CROX) Shares Fly 26% But Investors Aren't Buying For Growth
May 31Crocs, Inc. (NASDAQ:CROX) Shares Could Be 48% Below Their Intrinsic Value Estimate
May 29Crocs, Inc.'s (NASDAQ:CROX) CEO Will Probably Have Their Compensation Approved By Shareholders
May 29Crocs: Strategic Catalysts To Drive Sustained Growth
May 18Crocs: Maintaining My 'Buy' Rating As Headwinds From Heydude Likely Priced In
May 11We Think Crocs (NASDAQ:CROX) Can Stay On Top Of Its Debt
Apr 21Crocs: Off-The-Radar Compounder With Great Potential
Apr 09Here's Why We Think Crocs (NASDAQ:CROX) Might Deserve Your Attention Today
Mar 18Crocs Q4: Looking For HEYDUDE To Rebound In Second Half
Mar 07There's No Escaping Crocs, Inc.'s (NASDAQ:CROX) Muted Earnings Despite A 27% Share Price Rise
Mar 03Crocs, Inc. Just Beat EPS By 11%: Here's What Analysts Think Will Happen Next
Feb 17When Should You Buy Crocs, Inc. (NASDAQ:CROX)?
Feb 08Crocs Q4 Estimates Show The Company Still Has Legs
Feb 07Crocs Clogs Are Good, But The Stock Is Even Better
Jan 31Crocs (NASDAQ:CROX) Seems To Use Debt Quite Sensibly
Jan 08Fewer Investors Than Expected Jumping On Crocs, Inc. (NASDAQ:CROX)
Dec 24With EPS Growth And More, Crocs (NASDAQ:CROX) Makes An Interesting Case
Nov 28What Does Crocs, Inc.'s (NASDAQ:CROX) Share Price Indicate?
Oct 11Crocs (NASDAQ:CROX) Has A Pretty Healthy Balance Sheet
Sep 08Does Crocs (NASDAQ:CROX) Deserve A Spot On Your Watchlist?
Aug 21Why Crocs, Inc. (NASDAQ:CROX) Could Be Worth Watching
Jul 06Is Crocs (NASDAQ:CROX) Using Too Much Debt?
May 12When Should You Buy Crocs, Inc. (NASDAQ:CROX)?
Apr 06Estimating The Intrinsic Value Of Crocs, Inc. (NASDAQ:CROX)
Mar 22Crocs (NASDAQ:CROX) Seems To Use Debt Quite Sensibly
Feb 07Is Now The Time To Look At Buying Crocs, Inc. (NASDAQ:CROX)?
Jan 01Is There An Opportunity With Crocs, Inc.'s (NASDAQ:CROX) 45% Undervaluation?
Nov 25Crocs (NASDAQ:CROX) Has A Pretty Healthy Balance Sheet
Oct 29Crocs: Why This Iconic Brand Is A Long Term Winner
Sep 23Is Now An Opportune Moment To Examine Crocs, Inc. (NASDAQ:CROX)?
Sep 20Crocs: A Multi-Year Compounder
Sep 13Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 4,557 | 858 | 897 | 1,129 | 4 |
12/31/2025 | 4,382 | 806 | 798 | 1,011 | 12 |
12/31/2024 | 4,146 | 726 | 702 | 898 | 12 |
3/31/2024 | 4,017 | 795 | 789 | 893 | N/A |
12/31/2023 | 3,962 | 793 | 815 | 930 | N/A |
9/30/2023 | 3,947 | 677 | 836 | 937 | N/A |
6/30/2023 | 3,887 | 669 | 750 | 849 | N/A |
3/31/2023 | 3,779 | 617 | 590 | 682 | N/A |
12/31/2022 | 3,555 | 540 | 499 | 603 | N/A |
9/30/2022 | 3,196 | 557 | 349 | 459 | N/A |
6/30/2022 | 2,837 | 541 | 318 | 410 | N/A |
3/31/2022 | 2,513 | 700 | 381 | 468 | N/A |
12/31/2021 | 2,313 | 726 | 511 | 567 | N/A |
9/30/2021 | 2,138 | 754 | 419 | 463 | N/A |
6/30/2021 | 1,874 | 663 | 430 | 469 | N/A |
3/31/2021 | 1,565 | 400 | 348 | 382 | N/A |
12/31/2020 | 1,386 | 313 | 225 | 267 | N/A |
9/30/2020 | 1,237 | 149 | 138 | 175 | N/A |
6/30/2020 | 1,188 | 123 | 68 | 110 | N/A |
3/31/2020 | 1,216 | 106 | 27 | 69 | N/A |
12/31/2019 | 1,231 | 119 | 53 | 90 | N/A |
9/30/2019 | 1,184 | -11 | 62 | 101 | N/A |
6/30/2019 | 1,132 | -41 | 66 | 93 | N/A |
3/31/2019 | 1,101 | -55 | 76 | 97 | N/A |
12/31/2018 | 1,088 | -69 | 102 | 114 | N/A |
9/30/2018 | 1,071 | 17 | 100 | 104 | N/A |
6/30/2018 | 1,054 | 9 | 96 | 100 | N/A |
3/31/2018 | 1,039 | -1 | 92 | 102 | N/A |
12/31/2017 | 1,024 | -5 | N/A | 98 | N/A |
9/30/2017 | 1,012 | -23 | N/A | 91 | N/A |
6/30/2017 | 1,014 | -26 | N/A | 59 | N/A |
3/31/2017 | 1,025 | -31 | N/A | 47 | N/A |
12/31/2016 | 1,036 | -32 | N/A | 40 | N/A |
9/30/2016 | 1,058 | -63 | N/A | 32 | N/A |
6/30/2016 | 1,086 | -86 | N/A | 33 | N/A |
3/31/2016 | 1,108 | -87 | N/A | -1 | N/A |
12/31/2015 | 1,091 | -98 | N/A | 10 | N/A |
9/30/2015 | 1,088 | -76 | N/A | 1 | N/A |
6/30/2015 | 1,117 | -38 | N/A | 2 | N/A |
3/31/2015 | 1,148 | -30 | N/A | 4 | N/A |
12/31/2014 | 1,198 | -19 | N/A | -12 | N/A |
9/30/2014 | 1,220 | -34 | N/A | -16 | N/A |
6/30/2014 | 1,207 | -31 | N/A | 29 | N/A |
3/31/2014 | 1,193 | -13 | N/A | 55 | N/A |
12/31/2013 | 1,193 | 10 | N/A | 83 | N/A |
9/30/2013 | 1,189 | 74 | N/A | 115 | N/A |
6/30/2013 | 1,196 | 105 | N/A | 116 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CROXDas prognostizierte Gewinnwachstum (5.6% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: CROXDie Erträge des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.7% pro Jahr).
Hohe Wachstumserträge: CROXDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: CROXDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.4% pro Jahr).
Hohe Wachstumseinnahmen: CROXDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: CROXDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (30.8%)